These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 37533264)

  • 61. Heterogeneity in endoscopic treatment of Crohn's disease-associated strictures: An international inflammatory bowel disease specialist survey.
    Bettenworth D; Lopez R; Hindryckx P; Levesque BG; Rieder F
    J Gastroenterol; 2016 Oct; 51(10):939-48. PubMed ID: 26831355
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Serum matrix metalloproteinase-9 concentration as a marker of disease activity in patients with inflammatory bowel disease.
    Shamseya AM; Hussein WM; Elnely DA; Adel F; Header DA
    Eur J Gastroenterol Hepatol; 2021 Dec; 33(1S Suppl 1):e803-e809. PubMed ID: 34678857
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Recommendations of the Spanish Working Group on Crohn's Disease and Ulcerative Colitis (GETECCU) and the Association of Crohn's Disease and Ulcerative Colitis Patients (ACCU) in the management of psychological problems in Inflammatory Bowel Disease patients.
    Barreiro-de Acosta M; Marín-Jiménez I; Panadero A; Guardiola J; Cañas M; Gobbo Montoya M; Modino Y; Alcaín G; Bosca-Watts MM; Calvet X; Casellas F; Chaparro M; Fernández Salazar L; Ferreiro-Iglesias R; Ginard D; Iborra M; Manceñido N; Mañosa M; Merino O; Rivero M; Roncero O; Sempere L; Vega P; Zabana Y; Mínguez M; Nos P; Gisbert JP
    Gastroenterol Hepatol; 2018 Feb; 41(2):118-127. PubMed ID: 29275001
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Inflammatory bowel disease register: Steps towards Crohn's & colitis foundation of Saudi Arabia (CCFSA).
    Masoodi I; Alsayari K; Albishri J
    Int J Health Sci (Qassim); 2012 Jun; 6(2):232-6. PubMed ID: 23580900
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Crohn's disease and ulcerative colitis. Occurrence, course and prognosis during the first year of disease in a European population-based inception cohort.
    Burisch J
    Dan Med J; 2014 Jan; 61(1):B4778. PubMed ID: 24393595
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Urotensin II levels in patients with inflammatory bowel disease.
    Alicic D; Martinovic D; Rusic D; Zivkovic PM; Tadin Hadjina I; Vilovic M; Kumric M; Tokic D; Supe-Domic D; Lupi-Ferandin S; Bozic J
    World J Gastroenterol; 2021 Sep; 27(36):6142-6153. PubMed ID: 34629825
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Physicians' Knowledge and Application of Immunization Strategies in Patients with Inflammatory Bowel Disease: A Survey of the Italian Group for the Study of Inflammatory Bowel Disease.
    Macaluso FS; Mazzola G; Ventimiglia M; Alvisi P; Renna S; Adamoli L; Galli M; Armuzzi A; Ardizzone S; Cascio A; Cottone M; Orlando A;
    Digestion; 2020; 101(4):433-440. PubMed ID: 31167191
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Prodromal irritable bowel syndrome may be responsible for delays in diagnosis in patients presenting with unrecognized Crohn's disease and celiac disease, but not ulcerative colitis.
    Barratt SM; Leeds JS; Robinson K; Lobo AJ; McAlindon ME; Sanders DS
    Dig Dis Sci; 2011 Nov; 56(11):3270-5. PubMed ID: 21695401
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Urinary excretion of N-methylhistamine as a marker of disease activity in inflammatory bowel disease.
    Winterkamp S; Weidenhiller M; Otte P; Stolper J; Schwab D; Hahn EG; Raithel M
    Am J Gastroenterol; 2002 Dec; 97(12):3071-7. PubMed ID: 12492192
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Perspectives of East Asian patients and physicians on complementary and alternative medicine use for inflammatory bowel disease: results of a cross-sectional, multinational study.
    Kim ES; Tae CH; Jung SA; Park DI; Im JP; Eun CS; Yoon H; Jang BI; Ogata H; Fukuhara K; Hirai F; Ohtsuka K; Liu J; Cao Q;
    Intest Res; 2022 Apr; 20(2):192-202. PubMed ID: 35508953
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Immune-Mediated Inflammatory Diseases Awareness and Management among Physicians Treating Patients with Inflammatory Bowel Disease: An IG-IBD Survey.
    Vernero M; Bezzio C; Ribaldone DG; Caprioli FA; Fantini MC; Festa S; Macaluso FS; Orlando A; Pugliese D; Renna S; Rispo A; Savarino EV; Variola A; Saibeni S;
    J Clin Med; 2024 Mar; 13(7):. PubMed ID: 38610623
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Focally enhanced gastritis in children with Crohn's disease and ulcerative colitis.
    Sharif F; McDermott M; Dillon M; Drumm B; Rowland M; Imrie C; Kelleher S; Harty S; Bourke B
    Am J Gastroenterol; 2002 Jun; 97(6):1415-20. PubMed ID: 12094859
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Incidence of inflammatory bowel disease in northern France (1988-1990).
    Gower-Rousseau C; Salomez JL; Dupas JL; Marti R; Nuttens MC; Votte A; Lemahieu M; Lemaire B; Colombel JF; Cortot A
    Gut; 1994 Oct; 35(10):1433-8. PubMed ID: 7959201
    [TBL] [Abstract][Full Text] [Related]  

  • 74. SURGICAL MANAGEMENT OF ADULT CROHN'S DISEASE AND ULCERATIVE COLITIS PATIENTS: A CONSENSUS FROM THE BRAZILIAN ORGANIZATION OF CROHN'S DISEASE AND COLITIS (GEDIIB).
    Zabot GP; Cassol OS; Quaresma AB; Gonçalves Filho FA; Baima JP; Imbrizi M; Rolim AS; Carmo AMD; Alves Junior AJT; Santos CHMD; Sobrado Junior CW; Miranda EF; Albuquerque IC; Souza MM; Kaiser Junior RL; Parra RS; Kotze PG; Saad-Hossne R
    Arq Gastroenterol; 2023; 59(suppl 1):1-19. PubMed ID: 36995887
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Comparison of serological markers of inflammatory bowel disease with clinical diagnosis in children.
    Gupta SK; Fitzgerald JF; Croffie JM; Pfefferkorn MD; Molleston JP; Corkins MR
    Inflamm Bowel Dis; 2004 May; 10(3):240-4. PubMed ID: 15290918
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Challenging the Surge of Inflammatory Bowel Disease: The Role of the China Crohn's and Colitis Foundation in the Healthcare Landscape of Inflammatory Bowel Disease.
    Peng L; Hu S; Yu Q; Chen Y
    Inflamm Bowel Dis; 2022 Jun; 28(Suppl 2):S9-S15. PubMed ID: 34984463
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Antibiotic use and the development of inflammatory bowel disease: a national case-control study in Sweden.
    Nguyen LH; Örtqvist AK; Cao Y; Simon TG; Roelstraete B; Song M; Joshi AD; Staller K; Chan AT; Khalili H; Olén O; Ludvigsson JF
    Lancet Gastroenterol Hepatol; 2020 Nov; 5(11):986-995. PubMed ID: 32818437
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Management consensus of inflammatory bowel disease for the Asia-Pacific region.
    Ouyang Q; Tandon R; Goh KL; Pan GZ; Fock KM; Fiocchi C; Lam SK; Xiao SD
    J Gastroenterol Hepatol; 2006 Dec; 21(12):1772-82. PubMed ID: 17074013
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Incidence of Crohn's Disease and Ulcerative Colitis in Rhode Island: Report from the Ocean State Crohn's and Colitis Area Registry.
    Shapiro JM; Zoega H; Shah SA; Bright RM; Mallette M; Moniz H; Grabert SA; Bancroft B; Merrick M; Flowers NT; Samad Z; Lidofsky S; LeLeiko NS; Sands BE
    Inflamm Bowel Dis; 2016 Jun; 22(6):1456-61. PubMed ID: 26926039
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Development of a quality-of-life index for pediatric inflammatory bowel disease: dealing with differences related to age and IBD type.
    Griffiths AM; Nicholas D; Smith C; Munk M; Stephens D; Durno C; Sherman PM
    J Pediatr Gastroenterol Nutr; 1999 Apr; 28(4):S46-52. PubMed ID: 10204526
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.